Cagrilintide

Cagrilintide is a long-acting amylin analog peptide developed to aid weight loss and appetite regulation. It works by slowing gastric emptying, increasing satiety, and reducing overall food intake. When combined with GLP-1 receptor agonists like semaglutide, it enhances fat loss synergistically. Cagrilintide also helps improve metabolic control and insulin sensitivity. It is being researched for obesity and type 2 diabetes management, showing promising results in reducing body weight and improving energy balance.